American Portfolios Advisors Biomarin Pharmaceutical Inc Transaction History

American Portfolios Advisors

$2.36 Trillion
Q3 2022

A detailed history of American Portfolios Advisors transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, American Portfolios Advisors holds 423 shares of BMRN stock, worth $29,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares

423

Holding current value

$29,732

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 17, 2023	BUY	$82.16 - $96.94 $34,753 - $41,005	423 New	423 $35.9 Million
Q2 2022 Mar 20, 2023	BUY	$71.48 - $86.85 $8,506 - $10,335	119 Added 28.13%	542 $44.9 Million
Q1 2022 Mar 21, 2023	BUY	$74.28 - $92.69 $8,022 - $10,010	108 Added 25.53%	531 $40.9 Million
Q4 2021 Mar 21, 2023	BUY	$71.72 - $91.47 $3,514 - $4,482	49 Added 11.58%	472 $41.7 Million
Q3 2021 Mar 22, 2023	BUY	$74.77 - $85.47 $8,149 - $9,316	109 Added 25.77%	532 $41.1 Million
Q2 2021 Mar 22, 2023	BUY	$75.51 - $84.79 $1,736 - $1,950	23 Added 5.44%	446 $37.2 Million
Q1 2021 Mar 22, 2023	SELL	$74.73 - $90.69 $597 - $725	-8 Reduced 1.89%	415 $31.3 Million
Q4 2020 Mar 22, 2023	SELL	$72.61 - $90.2 $580 - $721	-8 Reduced 1.89%	415 $36.4 Million
Q3 2020 Mar 22, 2023	SELL	$71.87 - $131.03 $5,749 - $10,482	-80 Reduced 18.91%	343 $26.1 Million
Q2 2020 Mar 24, 2023	SELL	$79.55 - $124.22 $477 - $745	-6 Reduced 2.25%	261 $32.2 Million
Q1 2020 Mar 24, 2023	SELL	$71.37 - $96.85 $11,133 - $15,108	-156 Reduced 36.88%	267 $22.6 Million
Q4 2019 Mar 24, 2023	SELL	$64.27 - $86.37 $14,910 - $20,037	-232 Reduced 54.85%	191 $16.1 Million
Q3 2019 Mar 24, 2023	BUY	$67.4 - $85.11 $6,133 - $7,745	91 Added 137.88%	157 $10.6 Million
Q2 2019 Mar 24, 2023	SELL	$80.35 - $93.9 $28,684 - $33,522	-357 Reduced 84.4%	66 $5.65 Million
Q4 2018 Mar 24, 2023	SELL	$80.14 - $106.07 $30,292 - $40,094	-378 Reduced 89.36%	45 $3.83 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Account

American Portfolios Advisors Biomarin Pharmaceutical Inc Transaction History